As the global population continues to age, the prevalence of conditions associated with old age has also risen. For Alzheimer’s disease, this means that there is an expected tripling of the burden of disease worldwide, and currently, there is no way to delay the disease’s progression. So while we live in the golden age of neuroscience – knowing more about the neurological system than ever before, there is more to be done, which is why I chose to make the development of new approaches in this area my first priority as the head of the Neuroscience Therapeutic Area at Janssen.

A guest blog by Husseini Manji, Global Head of the Neuroscience Therapeutic Area at Janssen Research & Development